2028 Healthcare Physicians 
Medico Reach
JUNE 16, 2022
Infographic content: The onset of the COVID-19 pandemic has pushed significant growth in the US Healthcare Industry, with 2022 being the year of consumer influence. With higher interoperability levels and significantly better price transparency for medical bills and drugs, the US healthcare industry is dead set on growth.
Nixon Gwilt Law
MAY 26, 2023
As a law firm focused specifically on healthcare innovation, we get really excited about developing areas of the healthcare industry. Digital health companies building VR solutions often ask us this question, and if you are a founder or executive looking for ways to commercialize your VR platform for healthcare providers in the U.S.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
JUNE 24, 2024
In the rapidly evolving global healthcare landscape, the relationship between patients and healthcare professionals (HCPs) remains crucial for effective treatment and care delivery. Another survey found that only 12% of adults felt healthcare was handled ‘extremely’ or ‘very’ well in the U.S.,
PM360
SEPTEMBER 21, 2023
As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. After this period, CMS will begin to include physician-administered drugs covered under Part B in the program.
InCrowd
AUGUST 11, 2022
with the strongest opinions being on accuracy of the tests and the importance of consulting with a healthcare provider. We asked respondents to elaborate on how someone who is interested in accessing genetic counseling should go about the process of contacting a Genetic Counselor through a healthcare provider.
Clarivate
OCTOBER 25, 2023
The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.
PM360
APRIL 7, 2023
Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.
Expert insights. Personalized for you.
98 
Let's personalize your content